It was proved that the dysregulation of serotonergic or adrenergic neurotransmission in addition to abnormalities in the function of corticotropin-releasing factor (CRF) may play a significant role in the pathophysiology of both depression and OAB [6]. This evidence concerns the gene CRH and depressive symptom measurement.